GS
PFE icon

GTS Securities’s Pfizer PFE Stock Holding History

GTS Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,269,000
Closed -$36.7M – 3272
2024
Q3 		$36.7M Sell
1,269,000
-399,600
-24% -$11.7M 0.08% 141
2024
Q2 		$46.7M Sell
1,668,600
-786,100
-32% -$21.6M 0.1% 109
2024
Q1 		$68.1M Sell
2,454,700
-590,400
-19% -$16.4M 0.13% 73
2023
Q4 		$87.7M Buy
3,045,100
+1,381,800
+83% +$41.8M 0.15% 60
2023
Q3 		$55.2M Buy
+1,663,300
New +$58.8M 0.1% 102

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

GTS Securities's PFE Position: Q1 2026 in Review

GTS Securities reduced its Pfizer (PFE) stake by 75% in Q1 2026, selling an estimated $1.14M and leaving 14,579 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #872.

GTS Securities first reported a position in PFE in Q2 2023 and has held it in 11 quarters since. The position peaked at $41.8M in Q4 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • GTS Securities held 14,579 shares of Pfizer worth $409K as of Q1 2026.
  • GTS Securities sold 42,781 Pfizer shares in Q1 2026, an estimated $1.14M.
  • Pfizer made up 0.01% of GTS Securities's portfolio in Q1 2026, its #872 holding.
  • GTS Securities first reported a position in Pfizer in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's Pfizer position peaked at $41.8M in Q4 2023.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.